DUBLIN, Ohio (AP) _ Navidea Biopharmaceuticals Inc. (NAVB) on Wednesday reported a loss of $3.8 million in its third quarter.
On a per-share basis, the Dublin, Ohio-based company said it had a loss of 2 cents.
The biopharmaceutical posted revenue of $231,500 in the period. Its adjusted revenue was $231,000.
In the final minutes of trading on Wednesday, the company's shares hit 25 cents. A year ago, they were trading at 43 cents.
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on NAVB at https://www.zacks.com/ap/NAVB